Search
for
Sort by
Research 871–900 of 1000+
- A Study of Correlation of Alopecia Areata and Metabolic Syndrome in Northwest Indian Population
- Disease-related biomarkers as experimental endpoints in 3D skin culture models
- A Pilot Randomized Controlled Trial Comparing the Efficacy and Safety of Oral Tofacitinib Versus Methotrexate In Moderate-to-Severe Alopecia Areata
- A Comprehensive Review on Alopecia: Mechanisms, Classification, and Therapeutic Strategies
- A Comprehensive Review on Alopecia: Mechanisms, Classification, and Therapeutic Strategies
- 477 How Cannabidiol Supports Hair Growth: From Epigenetics to the Scalp Microbiome
- Tofacitinib in the Recalcitrant Cases of Alopecia Areata: A Pilot Study
- Baricitinib in the Management of Coexisting Alopecia Areata and Atopic Dermatitis: A Case Report
- 6ER-014 Evaluation of baricitinib in paediatric patients with alopecia areata
- 5PSQ-117 Effectiveness of baricitinib in alopecia areata
- Tru9I Variant as a Novel Genetic Marker for Vitamin D Deficiency in Alopecia Areata
- LB1048 Effectiveness of OR-101 in a murine model of atopic dermatitis
- Transcriptome analysis of frontal fibrosis alopecia revealed involvement of immune cells and ferroptosis
- Effect of fractional laser alone or in combination on alopecia areata: A systematic review and meta‐analysis
- Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
- Analysing the dynamics of a model for alopecia areata as an autoimmune disorder of hair follicle cycling
- Increased proliferation of epidermal gamma delta T cells and expression of the transmembrane protein, BST2, in Alopecia areata
- Spontaneous complete resolution of alopecia totalis post SARS-CoV-2 infection
- In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of Jak3 Kinase And 5-Alpha Reductase Type II with ADMET Profiling
- In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of Jak3 Kinase And 5-Alpha Reductase Type II with ADMET Profiling
- 0480 Upadacitinib monotherapy for treatment of pyoderma gangrenosum: A case series
- 808 Lichen planus single cell and spatial profiling of cutaneous lichen planus treated with baricitinib
- 294 Extensive alopecia areata is reversed by IL-12/23p40 cytokine antagonism
- Application of Baricitinib in Dermatology
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Transcutaneous Auricular Vagus Nerve Stimulation Alleviates Monobenzone-Induced Vitiligo in Mice
- Recovery of nail dystrophy potential new therapeutic indication of tofacitinib
- Causal relationship between inflammatory cytokines and polycystic ovary syndrome: a bidirectional mendelian randomization study
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib